Physician profile
Matthew Evans
NPI 1083876940
$2,247.69
in general payments reported to CMS, 2019-2025
17 companies · $694 in 2025
The $694 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.20 · 2020: $14.41 · 2021: $249 · 2022: $95.16 · 2023: $126 · 2024: $976 · 2025: $694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,585 · Food and Beverage: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,585.15 |
| Food and Beverage | $211.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $932.18 | 2024 | Pulseselect |
| Biotronik INC. | $652.97 | 2025 | |
| Novartis Pharmaceuticals Corporation | $142.04 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $99.99 | 2021 | |
| Janssen Pharmaceuticals, INC | $68.22 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.20 | 2019-2020 | |
| Abbott Laboratories | $49.07 | 2021-2025 | Gallant |
| Baxter Healthcare | $43.99 | 2024 | Preveleak |
| Tactile Systems Technology INC | $33.59 | 2023 | Flexitouch Plus, Entre Plus |
| Kestra Medical Technology Services, INC. | $33.27 | 2023 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $30.15 | 2023 | Eliquis |
| Cardiva Medical, INC. | $24.02 | 2022 | |
| Smith+Nephew, INC. | $16.72 | 2021 | |
| Amgen INC. | $16.33 | 2019 | |
| Amarin Pharma, INC. | $15.28 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.87 | 2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.